ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European...
17 insider purchases on record · latest filing 2024-12-13.
Insiders have also filed 16 sale transactions at ADCT.